Immunodiagnostics Market in North America to 2030 - By Size, Share, Growth by End User and Forecast | Business Market in North America Insights

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Immunodiagnostics Market – by Product

1.3.2 North America Immunodiagnostics Market – by Clinical Indication

1.3.3 North America Immunodiagnostics Market – by End User

1.3.4 North America Immunodiagnostics Market – by Country

2. North America Immunodiagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Immunodiagnostics Market – Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Expert’s Opinion

5. North America Immunodiagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Infectious Diseases

5.1.2 Growing Use of Point-of-Care Immunodiagnostics

5.2 Market Restraints

5.2.1 Inadequate Reimbursement Scenario

5.3 Market Opportunities

5.3.1 Rising Focus on R&D Investment and Expansion by Key Players

5.4 Future Trends

5.4.1 Technological Advancements in Immunodiagnostics

5.5 Impact Analysis

6. Immunodiagnostics Market – North America Analysis

6.1 North America Immunodiagnostics Market Revenue Forecast and Analysis

7. North America Immunodiagnostics Market Analysis – by Product

7.1 Overview

7.2 North America Immunodiagnostics Market, By Product, 2022 & 2030 (%)

7.3 Enzyme-linked Immunosorbent Assays (ELISA)

7.3.1 Overview

7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4 Chemiluminescence Immunoassays (CLIA)

7.4.1 Overview

7.4.2 Chemiluminescence Immunoassays (CLIA): North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.3 Vitamin D Assay

7.4.3.1 Overview

7.4.3.2 Vitamin D Assay: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.4 HIV Detection

7.4.4.1 Overview

7.4.4.2 HIV Detection: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.5 HIV Ag/Ab Combo assay

7.4.5.1 Overview

7.4.5.2 HIV Ag/Ab Combo Assay: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.6 Other Tests

7.4.6.1 Overview

7.4.6.2 Other Tests: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.5 Radioimmunoassays (RIA)

7.5.1 Overview

7.5.2 Radioimmunoassays (RIA): North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. North America Immunodiagnostics Market Analysis – Clinical Indication

8.1 Overview

8.2 North America Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)

8.3 Infectious Diseases:

8.3.1 Overview

8.3.2 Infectious Diseases: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.1 COVID-19

8.3.2.1.1 Overview

8.3.2.1.2 COVID-19: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.2 Tuberculosis

8.3.2.2.1 Overview

8.3.2.2.2 Tuberculosis: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.3 Lyme

8.3.2.3.1 Overview

8.3.2.3.2 Lyme: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.4 Infection Management

8.3.2.4.1 Overview

8.3.2.4.2 Infection Management: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.5 Zika

8.3.2.5.1 Overview

8.3.2.5.2 Zika: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.6 Treponema

8.3.2.6.1 Overview

8.3.2.6.2 Treponema: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.7 TORCH

8.3.2.7.1 Overview

8.3.2.7.2 TORCH: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.8 Measles and Mumps

8.3.2.8.1 Overview

8.3.2.8.2 Measles and Mumps: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.9 VZV

8.3.2.9.1 Overview

8.3.2.9.2 VZV: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.10 EBV

8.3.2.10.1 Overview

8.3.2.10.2 EBV: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.4 Hepatitis+HIV:

8.4.1 Overview

8.4.2 Hepatitis+HIV: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.5 Gastrointestinal

8.5.1 Overview

8.5.2 Gastrointestinal: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.6 Metabolic Disorders

8.6.1 Overview

8.6.2 Metabolics: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7 Endocrinology

8.7.1 Overview

8.7.2 Endocrinology: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.3 Hypertension

8.7.3.1 Overview

8.7.3.2 Hypertension: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.4 Growth

8.7.4.1 Overview

8.7.4.2 Growth: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.5 Diabetes

8.7.5.1 Overview

8.7.5.2 Diabetes: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.6 Thyroid

8.7.6.1 Overview

8.7.6.2 Thyroid: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.7 Reproductive Endocrinology

8.7.7.1 Overview

8.7.7.2 Reproductive Endocrinology: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. North America Immunodiagnostics Market Analysis – End User

9.1 Overview

9.2 North America Immunodiagnostics Market Share by End User - 2022 & 2030 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.5 Diagnostic Laboratories

9.5.1 Overview

9.5.2 Diagnostic Laboratories: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.6 Academic and Research Institutes

9.6.1 Overview

9.6.2 Academic and Research Institutes: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. North America Immunodiagnostics Market – Revenue and Forecast to 2030 – Country Analysis

10.1 Overview

10.1.1.1 US: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 US: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3 US: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.1.3.1 US: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4 US: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4.1 US: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4.2 US: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.5 US: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.2 Canada: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Canada: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 Canada: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.2.3.1 Canada: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4 Canada: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4.1 Canada: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4.2 Canada: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.5 Canada: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.3 Mexico: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 Mexico: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 Mexico: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.3.3.1 Mexico: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4 Mexico: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4.1 Mexico: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4.2 Mexico: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.5 Mexico: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

11. North America Immunodiagnostics Market –Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Abbott Laboratories

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F. Hoffmann-La Roche Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 DiaSorin SpA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Danaher Corp

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Thermo Fisher Scientific Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 PerkinElmer Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 bioMerieux SA

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Svar Life Science AB

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Siemens Healthcare GmbH

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. US Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 2. US Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 3. US Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 4. US Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 5. US Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 6. US Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 7. Canada Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 8. Canada Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 9. Canada Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 10. Canada: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 11. Canada Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 12. Canada Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 13. Mexico Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 14. Mexico Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 15. Mexico Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 16. Mexico: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 17. Mexico Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 18. Mexico Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 19. Recent Inorganic Growth Strategies in the Immunodiagnostics Market

Table 20. Recent Organic Growth Strategies in the Immunodiagnostics Market

Table 21. Glossary of Terms, North America Immunodiagnostics Market

LIST OF FIGURES

Figure 1. North America Immunodiagnostics Market Segmentation

Figure 2. North America Immunodiagnostics Market, by Country

Figure 3. North America Immunodiagnostics Market Overview

Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in North America Immunodiagnostics Market

Figure 5. Canada Expected to Show Remarkable Growth During Forecast Period

Figure 6. North America: PEST Analysis

Figure 7. Experts’ Opinion

Figure 8. North America Immunodiagnostics Market: Impact Analysis of Drivers and Restraints

Figure 9. North America Immunodiagnostics Market – Revenue Forecast and Analysis – 2021–2030

Figure 10. North America Immunodiagnostics Market, by Product, 2022 & 2030 (%)

Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 12. Chemiluminescence Immunoassays (CLIA): North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 13. Vitamin D Assay: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 14. HIV Detection: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 15. HIV Ag/Ab Combo Assay: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 16. Other Tests: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 17. Radioimmunoassays (RIA): North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 18. Others: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 19. North America Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)

Figure 20. Infectious Diseases: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 21. COVID-19: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 22. Tuberculosis: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 23. Lyme: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 24. Infection Management: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 25. Zika: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 26. Treponema: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 27. TORCH: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 28. Measles and Mumps: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 29. VZV: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 30. EBV: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 31. Hepatitis+HIV: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 32. Gastrointestinal: North America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 33. Metabolics: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 34. Endocrinology: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 35. Hypertension: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 36. Growth: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 37. Diabetes: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 38. Thyroid: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 39. Reproductive Endocrinology: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 40. Endocrinology: North America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 41. North America Immunodiagnostics Market Share by End User - 2022 & 2030 (%)

Figure 42. Hospitals: North America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 43. Clinics: North America Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)

Figure 44. Diagnostic Laboratories: North America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 45. Academic and Research Institutes: North America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 46. Others: North America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 47. North America: Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 48. North America: Immunodiagnostics Market, by Country, 2022 & 2030 (%)

Figure 49. US: Immunodiagnostics market – Revenue and Forecast to 2030 (US$ Million)

Figure 50. Canada: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 51. Mexico: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)